Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Lung Neoplasms 9Carcinoma, Non-Small-Cell Lung 3Smoking 1Small Cell Lung Carcinoma 1Pulmonary Nodule Cm 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mouth Neoplasms 1Lung Diseases 1Leukemia, Myeloid, Acute 1Leukemia 1Laryngeal Neoplasms 1Infections 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Graft vs Host Disease 1Congenital Abnormalities 1Carcinoma, Squamous Cell 1

Interventions

fludarabine phosphate 10Cyclophosphamide 10Peripheral Blood Stem Cell Transplantation 9Cyclosporine 7Mycophenolic Acid 6Filgrastim 6Antilymphocyte Serum 6Whole-Body Irradiation 5Busulfan 5Radiotherapy 4Psychiatric Rehabilitation 4Cytarabine 4Methylprednisolone 3Methotrexate 3Melphalan 3Cord Blood Stem Cell Transplantation 3Aprepitant 3thymoglobulin 2Therapeutics 2Tacrolimus 2Polymerase Chain Reaction 2Ondansetron 2Mesna 2Flow Cytometry 2Dexamethasone 2Calcium Dobesilate 2Analgesia 2sargramostim 1plerixafor 1fludarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Myeloproliferative Disorders × Bronchoscopy × Clear all
NCT00462657 2013-08-26

Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease

National Cancer Institute (NCI)

Phase NA Unknown
200 enrolled
LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Graft vs Host Disease, Infections, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡